Category biotech

United Therapeutics surges as Tyvaso succeeds in IPF trial: should you invest?
Shares of United Therapeutics jumped nearly 40% on Tuesday’s opening trade after the company reported its inhaled lung therapy Tyvaso met the main ...
Sep, 02, 2025
3 min read
by Invezz

Five sectors Warren Buffett continues to avoid in 2025
Legendary investor Warren Buffett’s iconic warning from his 1983 shareholder letter – likening major reinvestment in weak industries to “struggling...
Sep, 01, 2025
2 min read
by Invezz

Why big players are pouring millions in THIS biotech stock
Intellia Therapeutics (NASDAQ: NTLA) has been getting a lot of buzz lately among investors who follow the biotech space. The company uses CRISPR ge...
Sep, 01, 2025
2 min read
by Invezz

Biotech Isn’t Partaking In The IPO Rebound
The U.S. startup IPO market is coming back to life. Unless, that is, you’re a biotech company.
So far this year, just 16 funded U.S. startups in th...
Aug, 15, 2025
by Crunchbase